Current status of diagnosis and treatment of primary breast cancer in Beijing, 2008
Authors:
- 12 March 2011
- journal article
- research article
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 23 (1) , 38-42
Abstract
Objective To investigate the status of diagnosis and treatment of primary breast cancer in Beijing, 2008. Methods All the patients who were diagnosed as primary breast cancer in Beijing in 2008 were enrolled in this study. Information of these patients, including the features of tumors, clinical diagnosis and treatment was collected, and filled in the well-designed questionnaire forms by trained surveyors. The missing data were partly complemented through telephone interviews. Results A total of 3473 Beijing citizens were diagnosed as primary breast cancer (25 patients with synchronal bilateral breast cancer) in Beijing, 2008. Of them 82.09% were symptomatic. 19.02% and 34.11% were diagnosed using fine needle aspiration biopsy (FNAB) and core needle biopsy (CNB), respectively. 15.92% received sentinel lymph node biopsy (SLNB) and 24.27% received breast conserving surgery (BCS). Among 476 cases with Her-2 positive, only 96 received anti-Her-2 therapy. We found that the standardization level varied in hospitals of different grades, with higher level in Grade-III hospitals. Of note, some breast cancer patients received non-standard primary tumor therapy: 65.63% of the patients with ductal carcinoma in situ (DCIS) received axillary lymph node dissection and 36.88% received chemotherapy; 25.89% of the patients underwent breast conserving surgery without margin status; 12.10% of the patients received chemotherapy less than 4 cycles. Conclusion Although most breast cancer patients received basic medical care, the mode of diagnosis and treatment should be improved and should be standardized in the future in Beijing.Keywords
This publication has 18 references indexed in Scilit:
- Method of Detection and Breast Cancer Survival Disparities in Hispanic WomenCancer Epidemiology, Biomarkers & Prevention, 2010
- Population-based Estimate of the Prevalence of HER-2 Positive Breast Cancer Tumors for Early Stage Patients in the USCancer Investigation, 2010
- The Prognostic Significance of Micrometastases in Breast Cancer: A SEER Population-Based AnalysisAnnals of Surgical Oncology, 2007
- Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007Annals of Oncology, 2007
- Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patientsBreast Cancer Research, 2007
- The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodesCancer, 2005
- Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up.Journal of Clinical Oncology, 1993
- Pathologic findings from the national surgical adjuvant breast project protocol B-06 10-year pathologic and clinical prognostic discriminantsCancer, 1993
- Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.Journal of Clinical Oncology, 1991
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 1989